To ESG or not to ESG – is that a question?
29th October 2021
Start-up vs public market investing
20th May 2021
Getting our sleeves rolled up
3rd March 2021
The impact of COVID19 on seed investing
20th January 2021
The role of SEIS & EIS in a portfolio
3rd October 2020
Genius is evenly distributed, opportunity is not
14th September 2020
Post pandemic start-up valuations
18th June 2020
7 killer questions to ask an S/EIS Fund Manager
1st June 2020
When it’s risky, take risk
11th March 2020
SEIS: the ugly duckling or beautiful swan of early stage investing?
3rd March 2020
Obsessed about markets
21st January 2020
Beyond the cliché
23rd July 2019
SERENDIPITIOUS INNOVATION
8th March 2019
Our five criteria for selecting seed investments
18th December 2018
Autumn budget 2018
29th October 2018
Where seed investing fits in a portfolio
9th October 2018
A fair valuation for seed stage investments
24th August 2018
Spreading the word about EIS & SEIS
15th June 2018
The impact of portfolio investing
17th May 2018
Backing a growth market
5th March 2018
A TIME AND PLACE FOR CROWDFUNDING
6th February 2018
BUCKING THE BIAS – INVESTING IN MORE FEMALE AND REGIONAL ENTREPRENEURS
19th December 2017
5 questions for building a seed investment portfolio
20th October 2017
More similarities than differences between B2B and B2C
6th October 2017
THE PATIENT CAPITAL REVIEW
20th September 2017
Benchmarking seed investment returns
18th August 2017
The ‘world leading’ Seed Enterprise Investment Scheme
17th July 2017
Some relief from remarkable times
20th June 2017
